Publication & Citation Trends
Publications
0 total
A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan
Cited by 12
Semantic Scholar
Risk of permanent stoma after resection of rectal cancer depending on the distance between the tumour lower edge and anal verge.
Cited by 3
Semantic Scholar
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. OA
Cited by 1,883
Semantic Scholar
Quality indicators for colonoscopy and the risk of interval cancer. OA
Cited by 1,927
Semantic Scholar
Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome.
Cited by 67
Semantic Scholar
6078 Cetuximab plus FOLFIRI in 1st-line treatment of metastatic colorectal cancer: Quality of life (QoL) analysis of patients (pts) with KRAS wild-type (wt) tumours in the CRYSTAL trial
Cited by 8
Semantic Scholar
Cetuximab plus FOLFIRI first line in patients (pts) with metastatic colorectal cancer (mCRC): A quality-of-life (QoL) analysis of the CRYSTAL trial.
Cited by 7
Semantic Scholar
Research Topics
Colorectal Cancer Surgical Treatments
(25)
Colorectal and Anal Carcinomas
(25)
Colorectal Cancer Treatments and Studies
(15)
Colorectal Cancer Screening and Detection
(10)
Gastric Cancer Management and Outcomes
(10)
Affiliations
Merck (Germany)
University School of Physical Education in Kraków
Medical University of Warsaw
Sir Charles Gairdner Hospital
National Hospital